These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 14521139
1. [Comparison of piclamilast with ciclamilast in bronchodilating and antiallergic effects]. Ji H, Xie QM, Chen JQ. Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 32(4):274-8. PubMed ID: 14521139 [Abstract] [Full Text] [Related]
2. Selective inhibition of purified human phosphodiesterase 4A expressed in yeast cell GL62 by ciclamilast, piclamilast, and rolipram. Chen JC, Chen JQ, Xie QM, Zhu YL. Acta Pharmacol Sin; 2004 Sep; 25(9):1171-5. PubMed ID: 15339393 [Abstract] [Full Text] [Related]
3. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma. Deng YM, Xie QM, Tang HF, Sun JG, Deng JF, Chen JQ, Yang SY. Eur J Pharmacol; 2006 Oct 10; 547(1-3):125-35. PubMed ID: 16956605 [Abstract] [Full Text] [Related]
4. Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor. Raeburn D, Underwood SL, Lewis SA, Woodman VR, Battram CH, Tomkinson A, Sharma S, Jordan R, Souness JE, Webber SE. Br J Pharmacol; 1994 Dec 10; 113(4):1423-31. PubMed ID: 7889300 [Abstract] [Full Text] [Related]
5. Anti‑inflammatory effect of ciclamilast in an allergic model involving the expression of PDE4B. Zheng XY, Chen JC, Xie QM, Chen JQ, Tang HF. Mol Med Rep; 2019 Mar 10; 19(3):1728-1738. PubMed ID: 30628641 [Abstract] [Full Text] [Related]
6. [Antiallergic effects of tranilast in rats and guinea pigs]. Chen J, Cai S, Ye S, Xie Q, Yu F. Hua Xi Yi Ke Da Xue Xue Bao; 1997 Jun 10; 28(2):179-83. PubMed ID: 10683930 [Abstract] [Full Text] [Related]
7. Differential inhibition by selective phosphodiesterase inhibitors of antigen, LTC4 and histamine-induced contraction of guinea-pig isolated trachea. Planquois JM, Ruffin-Morin Y, Lagente V, Payne AN, Dahl SG. Pulm Pharmacol; 1996 Aug 10; 9(4):251-8. PubMed ID: 9160414 [Abstract] [Full Text] [Related]
8. Inhibition of bronchospasm and ozone-induced airway hyperresponsiveness in the guinea-pig by CDP840, a novel phosphodiesterase type 4 inhibitor. Holbrook M, Gozzard N, James T, Higgs G, Hughes B. Br J Pharmacol; 1996 Jul 10; 118(5):1192-200. PubMed ID: 8818343 [Abstract] [Full Text] [Related]
9. Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs. Howell RE, Sickels BD, Woeppel SL. J Pharmacol Exp Ther; 1993 Feb 10; 264(2):609-15. PubMed ID: 8437112 [Abstract] [Full Text] [Related]
10. Trachea relaxing effects and beta2-selectivity of SPFF, a newly developed bronchodilating agent, in guinea pigs and rabbits. Gan LL, Wang MW, Cheng MS, Pan L. Biol Pharm Bull; 2003 Mar 10; 26(3):323-8. PubMed ID: 12612441 [Abstract] [Full Text] [Related]
11. Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors. Wollin L, Bundschuh DS, Wohlsen A, Marx D, Beume R. Pulm Pharmacol Ther; 2006 Mar 10; 19(5):343-52. PubMed ID: 16257550 [Abstract] [Full Text] [Related]
12. In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor. Bundschuh DS, Eltze M, Barsig J, Wollin L, Hatzelmann A, Beume R. J Pharmacol Exp Ther; 2001 Apr 10; 297(1):280-90. PubMed ID: 11259555 [Abstract] [Full Text] [Related]
13. Differential in vivo and in vitro bronchorelaxant activities of CP-80,633, a selective phosphodiesterase 4 inhibitor. Wright KF, Turner CR, Jayasinghe-Beck R, Cohen VL, Cheng JB, Watson JW. Can J Physiol Pharmacol; 1997 Aug 10; 75(8):1001-8. PubMed ID: 9360015 [Abstract] [Full Text] [Related]
14. The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C(4)-induced contractions in passively sensitized human airways. Schmidt DT, Watson N, Dent G, Rühlmann E, Branscheid D, Magnussen H, Rabe KF. Br J Pharmacol; 2000 Dec 10; 131(8):1607-18. PubMed ID: 11139438 [Abstract] [Full Text] [Related]
15. Effects of piclamilast, a selective phosphodiesterase-4 inhibitor, on oxidative burst of sputum cells from mild asthmatics and stable COPD patients. Beeh KM, Beier J, Lerch C, Schulz AK, Buhl R. Lung; 2004 Dec 10; 182(6):369-77. PubMed ID: 15765929 [Abstract] [Full Text] [Related]
16. Inhibitor binding to type 4 phosphodiesterase (PDE4) assessed using [3H]piclamilast and [3H]rolipram. Zhao Y, Zhang HT, O'Donnell JM. J Pharmacol Exp Ther; 2003 May 10; 305(2):565-72. PubMed ID: 12704225 [Abstract] [Full Text] [Related]
18. Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer. Souness JE, Griffin M, Maslen C, Ebsworth K, Scott LC, Pollock K, Palfreyman MN, Karlsson JA. Br J Pharmacol; 1996 Jun 10; 118(3):649-58. PubMed ID: 8762090 [Abstract] [Full Text] [Related]
19. Dose dependent effects of tadalafil and roflumilast on ovalbumin-induced airway hyperresponsiveness in guinea pigs. Urbanova A, Medvedova I, Kertys M, Mikolka P, Kosutova P, Mokra D, Mokrý J. Exp Lung Res; 2017 Jun 10; 43(9-10):407-416. PubMed ID: 29220595 [Abstract] [Full Text] [Related]
20. NT-702 (parogrelil hydrochloride, NM-702), a novel and potent phosphodiesterase 3 inhibitor, suppress the asthmatic response in guinea pigs, with both bronchodilating and anti-inflammatory effects. Hori M, Iwama T, Asakura Y, Kawanishi M, Kamon J, Hoshino A, Takahashi S, Takahashi K, Nakaike S, Tsuruzoe N. Eur J Pharmacol; 2009 Sep 15; 618(1-3):63-9. PubMed ID: 19616537 [Abstract] [Full Text] [Related] Page: [Next] [New Search]